EU Commission: How to prepare for a "Hard Brexit"
Register now for ECA's GMP Newsletter
If a Withdrawal Agreement between the European Union (EU) and the United Kingdom (United Kingdom, UK) is not concluded, which would create a transitional period until the end of 2020 (with the possibility of an extension provided for in the withdrawal agreement), the United Kingdom will be treated as a non-EU country (literally as a third country) from 30 March 2019 - this also applies in particular to customs provisions.
The European Commission is now fostering its support in preparing EU companies for such a no deal scenario ("Hard Brexit").
The EU Commission now reiterates that affected companies must take all steps necessary before 30 March 2019 (or before a postponed date) to avoid possible adverse effects. To support this, the European Commission has set up a "Brexit Checklist" and its website with a list of practical tips and recommendations.
Related GMP News
26.06.202410 points on how the FDA's CDER monitors the Quality of Medicinal Products
08.05.2024EMA Plans for the next three Years
30.04.2024Lean GMP: is "right-sizing" GMP and Compliance possible?
24.04.2024Unexpected Deviations: the Role of the QP
10.04.2024FDA's current Thinking on KPIs and Quality Metrics
21.02.2024What is the African Medicines Agency?